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INTRODUCTION:  Endometrial  stromal  sarcomas  are  rare  mesenchymal  neoplasms  of  the uterus  with  an
indolent  clinical  course  but  a  high  risk  of recurrence.
PRESENTATION OF  CASE: We  report a case  of a  78  year  old  woman  who  presented  with  rectal  bleeding
and  recurrent  urinary  tract infections,  caused  by  a very  late  recurrence  of  a formerly  misdiagnosed  low





DISCUSSION: Endometrial  stromal  sarcomas  are  difﬁcult  to  diagnose,  both  due to the  rarity  of the  tumor
and  because  of the  close  resemblance  of the  tumor  to  normal  stromal  tissue.  These tumors  are  known
for  a high  tendency  of  recurrence,  therefore  long  term  follow  up is  required  in patients  with  endometrial
stromal  sarcoma.





Endometrial stromal sarcomas (ESS) are uncommon mesenchy-
al tumors of the uterus which are composed of cells closely
esembling normal proliferative endometrial stromal tissue.1 Tra-
itionally, ESS were classiﬁed into low-grade and high-grade ESS
ased on mitotic rate. High-grade tumors however, have little
esemblance to original endometrial stroma. Therefore, high-grade
umors are presently classiﬁed as undifferentiated endometrial or
terine sarcoma. In this classiﬁcation the differentiation between
ow-grade and undifferentiated tumors is not made on mitotic
ount but on the presence of nuclear pleomorphism and necrosis.1
tandard treatment for ESS is total abdominal hysterectomy and
ilateral salpingo-oophorectomy. When there is extra-uterine
pread complete debulking of all tumor is recommended.2 The
alue of adjuvant therapy is still controversial.
In this paper we present a patient presenting with rectal bleed-
ng, based on a very late recurrence of a formerly misdiagnosed
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low grade ESS metastasized to the colon. We  focus on pitfalls in the
diagnosis.
2. Presentation of a case
A  78 year old woman  presented with rectal bleeding and recur-
rent lower urinary tract infections in July 2009. Her medical history
showed a total abdominal hysterectomy and bilateral salpingo-
oophorectomy because of a uterus myomatosus with severe blood
loss in 1983 and a laparotomy with excision of a retroperitoneal cyst
in 1992. Pathological examination of the cyst showed a malignant
mesenchymal tumor.
Our  patient underwent a colonoscopy which revealed a malig-
nant circumferential obstructing tumor 28 cm from the anal verge
(Fig. 1). Histopathologic biopsies however, could not prove a malig-
nant origin. Computed tomography showed a suspicious tumor
of 8 cm,  at the site of the sigmoid, closely related to the urinary
bladder. Urine analysis revealed some atypical cells, but no signs
for urinary tract infection or malignant cells. Metastatic work-
up showed no signs of distant metastasis. Surgical resection was
achieved. Intraoperatively, a large tumoral process invading the
urinary bladder was discovered. A Hartmann’s resection was per-
formed with a partial cystectomy which was closed primarily
and the patient received a urinary catheter for one week. One
Open access under CC BY-NC-SA license.month postoperative she underwent intraperitoneal stomal revi-
sion, because of a retracted necrotizing colostomy. Further recovery
was uneventful. Pathologic examination showed a submucosal low
grade ESS of 8 cm in diameter arising from the colon with nodular
Ltd . Open access under CC BY-NC-SA license. 
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wFig. 1. Colonoscopy: stenosing tumor 28 cm from the anal verge.
nvasion of the mesocolon and three lymph nodes which all con-
ained metastases of ESS (Figs. 2 and 3). Resection margins were
ree from tumor.
In the context of this ﬁnding revision of the original resections
f the retroperitoneal cyst and the uterus and adnexa was per-
ormed. This revision revealed, both histomorphological as well as
mmunophenotypical, an equivalent aspect as the newly resected
olon tumor.
Final pathologic diagnosis therefore, was a very late colonic
ecurrence of a low grade uterine ESS.
. Discussion
Endometrial stromal sarcomas are rare tumors, contributing for
.2% of all uterine malignancies and 7–15% of all uterine sarcomas.3
nitially, histological classiﬁcation consisted of carcinosarcomas
40%), leiomyosarcomas (40%), ESS (15%) and undifferentiated sar-
omas (5%). Currently, the carcinosarcomas have been reclassiﬁed
s a differentiated or metaplastic form of endometrial carcinoma
ccording to the International Federation of Gynaecology and
bstetrics (FIGO) classiﬁcation.1
ESS are difﬁcult to diagnose because of close resemblance to
ormal proliferative endometrial cells, and because of the rarity
f the condition. Prior to surgical resection ESS are often mis-
iagnosed as leiomyoma or other uterine benign diseases and
fter resection also histological examination frequently misses the
iagnosis.2
ig. 2. Gross pathology of the opened sigmoid colon with the tumor in the center
ithout ulceration or erosion.Fig. 3. (A) Submucosal low-grade ESS. Pathologic analysis after rectosigmoid
resection 2009. HE, 12.5×. Tongues of small blue cells are permeating the muscularis
propria. (B). HE, 200×. A diffuse proliferation of spindle cells with little atypia.
Incidence peaks occur in premenopausal women between 40
and 55 years of age who are asymptomatic or present with vagi-
nal bleeding or pelvic or abdominal pain. ESS can occur in patients
with endometriosis and in patients with a prolonged exposure to
estrogens, e.g. patients with polycystic ovarian disease, or after
estrogen use or tamoxifen therapy.1,4 It is thought that the expo-
sure to estrogens causes a proliferative effect on the endometrial
stroma.
Stage is an important predictor of overall survival in these
tumors. Patients with stage I–II tumors have a 5-year over-
all survival of 89.3% compared to 50.3% in patients with stage
III–IV tumors.4 Eventually 15–25% of all patients will die of their
disease.3
3.1. Recurrence
Recurrences in low-grade ESS are common, even in early
stage disease. Tumor behaviour is apprehensive for a tendency
of late recurrence. In patients with stage I disease, the median
time to recurrence is 65 months compared to 9 months in
patients with stage III–IV ESS, therefore, long term follow-up is
recommended.4
Recurrences occur in 36–56% of patients, most frequently in the
pelvic cavity or the lungs.4,5 Metastatic spread to the cerebrum and
bones and invasion in the great vessels have also been described.6,7Recurrences in the abdominal cavity are rare. Recurrences aris-
ing in the small bowel and colon are intimately associated with
endometriosis.8 As the rectosigmoid has the highest incidence
of intestinal endometriosis, ESS arising within endometriosis are
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ost often diagnosed in the rectosigmoid.8 Our patient devel-
ped a very late recurrence in the rectosigmoid, although she
ad no history of endometriosis. Pathologic revision did not
eveal any signs of endometriosis, but the presence of a small
ndometriosis spot as an origin for the metastasis cannot be
xcluded.
.2. Treatment
Standard treatment for ESS is total abdominal hysterectomy
ith bilateral salpingo-oophorectomy, even at premenopausal
ges. The importance of comprehensive surgical staging remains
ebatable.3
Low grade endometrial sarcomas are usually characterized by
strogen and progesterone receptors.9 They are often sensitive to
ormones and it is presumed that patients preserving their ovaries
ave a higher risk of recurrence and poorer overall outcome.2,10
ome studies advocate considering re-exploration for removal of
varies6 while others state that ovarian preservation has no effect
n recurrences or overall survival.5,9 In premenopausal women
varies are frequently preserved, which does not affect the risk of
ecurrence in stage I patients.2,5
Lymph node metastases have been found in 7% of patients with
ow-grade ESS. Performing a lymph node dissection, regardless of
he ﬁnding of any microscopic positive nodes, does not have an
ffect on overall survival in low-grade ESS. Five-year survival is
5.7% in lymph node positive patients compared to 95.2% in lymph
ode negative patients.9
Adjuvant therapy following surgery can include radiotherapy,
hemotherapy and hormonal therapy. The value of adjuvant
herapy in low-grade ESS is still controversial.2,3 Post-operative
adiotherapy decreases the risk of local recurrence, especially in
rade II–IV disease, without having a signiﬁcant effect on over-
ll survival.2 Radiotherapy can also be given as palliation. Little is
nown about adjuvant chemotherapy, so no deﬁnitive recommen-
ations exist. Postoperative treatment with chemotherapy could
ight be an option in patients with hormone-unresponsive tumors
nd for inoperable patients.
Hormonal therapy can be an important treatment because of
he hormonal sensitivity of the tumor. Adjuvant progestagens
hould be considered in patients with ESS. In patients with com-
letely resected low-grade ESS it may  produce prolonged complete
esponse.5 Tamoxifen and estrogens are contraindicated because of
he possible stimulative effect on disseminated endometrial stro-
al  cells.2,5
Our patient underwent a hysterectomy in 1983 because of a
terus myomatosus accompanied with severe blood loss and exci-
ion of a retroperitoneal cyst in 1992. Retrospective pathologic
evision revealed ESS in both cases. That means our patient prob-
bly had stage I ESS in 1983, which was initially not recognized as
SS, but was probably regarded as a cell rich variant of leiomyoma.
fter nine years she developed the ﬁrst retroperitoneal recurrence.
t this time the tumor was detected as a malignant mesenchymal
umor, but was not recognized as ESS. Seventeen years later she
eveloped a second recurrence with a rare presentation. A recur-
ent ESS localized in the submucosa of the colon, in the absence of
ndometriosis, with ﬁxation to the urinary bladder is a very rare
nding.8 The accompanying lymphogenic spread is uncommon.
uring the ﬁrst surgery, at 52 years of age, our patient underwent
 hysterectomy for a uterus myomatosus with bilateral oophorec-
omy. She never took hormonal replacement therapy except for
ocal estrogens for a few weeks and she was not familiar with
ndometriosis. Prior to her third surgery in 2009, she was  diag-
osed with recurrent lower urinary tract infections. Urine analysis
evealed some atypical cells, presumably due to tumor invasion inPEN  ACCESS
ery Case Reports 4 (2013) 1113– 1116 1115
the urinary bladder. Final pathologic examination of the operatively
removed tumor however, could not conﬁrm spread of tumor into
the bladder wall, since no urinary bladder wall was recognized in
the specimen. Patient was discussed in our multidisciplinary oncol-
ogy panel and because of the controversy about adjuvant therapy
in the treatment of ESS, in combination with the radical surgery and
the long disease free period after the primary presentation and the
ﬁrst recurrence, no additional treatment was advised and follow up
will take place on a regular base once a year. Three years later the
patient has no evidence of disease.
4. Conclusion
In conclusion, low-grade ESS are uncommon tumors of
the uterus with an indolent clinical course and favourable
prognosis. Total abdominal hysterectomy with bilateral salpingo-
oophorectomy is the treatment of choice. In patients with a history
known for ESS, a recurrence should always be considered, despite a
very long disease-free interval. If recurrence occurs, radical surgery
should be performed and adjuvant hormonal therapy may  be con-
sidered.
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Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy
of the written consent is available for review by the Editor-in-Chief
of this journal on request.
Furthermore, patient information is anonymous and not trace-
able to the patient.
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